Which are the causes of Chronic lymphocytic leukemia (CLL)?

TL;DR: The exact cause of Chronic lymphocytic leukemia (CLL) remains unknown, as it typically develops from a combination of acquired genetic mutations and cellular aging rather than a single inherited defect. While Chronic lymphocytic leukemia (CLL) is not considered an "inherited" disease in the traditional sense, subtle genetic predispositions can increase individual risk.

What triggers the development of Chronic lymphocytic leukemia (CLL)?

The etiology of Chronic lymphocytic leukemia (CLL) involves the uncontrolled growth of abnormal B-lymphocytes—a type of white blood cell. Think of these cells as having a "broken" instruction manual that tells them to keep multiplying instead of dying off as they should. Research suggests that Chronic lymphocytic leukemia (CLL) begins with a single cell acquiring a genetic "glitch," which then replicates over many years.

Are there genetic factors linked to Chronic lymphocytic leukemia (CLL)?

While Chronic lymphocytic leukemia (CLL) is not typically passed directly from parent to child, certain chromosomal abnormalities are hallmark features of the disease. Clinical geneticists often monitor these markers to determine prognosis:

• Deletion 13q: The most common abnormality, often associated with a more favorable outlook.


• Trisomy 12: An extra copy of chromosome 12 found in many patients.


• Deletion 11q and 17p: These mutations are more complex and may require specialized treatment strategies.


• IGHV Mutation Status: Whether the immunoglobulin heavy chain variable region is mutated or unmutated helps doctors predict how the disease may progress.

What is the difference between causes and risk factors?

In Chronic lymphocytic leukemia (CLL), a "cause" would be the definitive biological event that initiates the cancer, which is currently under intense investigation. "Risk factors," conversely, are elements that increase the statistical likelihood of developing the condition. These include older age (median age at diagnosis is approximately 70 years), male gender, and a family history of lymphoproliferative disorders.

How is research advancing our understanding of this disease?

Current research is focused on the "microenvironment"—the surrounding bone marrow and lymph node cells that "feed" the leukemia cells. By understanding these interactions, scientists are developing targeted therapies that interrupt these growth signals, moving beyond traditional chemotherapy.

Next steps

• Consult a hematologist-oncologist to discuss your specific genetic profile (FISH and IGHV testing).


• Connect with the 26 members of the Chronic lymphocytic leukemia (CLL) community at DiseaseMaps.org for peer support.


• Visit the Leukemia & Lymphoma Society (LLS) website to search for active clinical trials.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Chronic Lymphocytic Leukemia


• The Leukemia & Lymphoma Society (LLS)


• PubMed: Molecular Pathogenesis of Chronic Lymphocytic Leukemia